Donald Trump's election might have been a big surprise to markets but the new administration has so far had a surprisingly positive effect on US equities.
Over the past few months US stocks have rallied, driven by the President's ambitions to push through an economic agenda that aims to inject fiscal stimulus into the economy, loosen regulation in several...
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds